𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Neoadjuvant chemotherapy and radical surgery in locally advanced cervical cancer. Prognostic factors for response and survival

✍ Scribed by Pierluigi Benedetti Panici; Giovanni Scambia; Gabriela Baiocchi; Stefano Greggi; Guglielmo Ragusa; Angelo Gallo; Massimo Conte; Francesco Battaglia; Giuseppe Laurelli; Carla Rabitti; Arnaldo Capelli; Salvatore Mancuso

Publisher
John Wiley and Sons
Year
1991
Tongue
English
Weight
702 KB
Volume
67
Category
Article
ISSN
0008-543X

No coin nor oath required. For personal study only.

πŸ“œ SIMILAR VOLUMES

Hormonal receptors in locally advanced b
Hormonal receptors in locally advanced breast cancer: Change with response to neoadjuvant chemotherapy?
✍ Don M. Morris; Jackie Edwards; Frank Gelder πŸ“‚ Article πŸ“… 1991 πŸ› John Wiley and Sons 🌐 English βš– 225 KB πŸ‘ 1 views

## Abstract Twenty‐one cancers in 20 patients with locally advanced breast cancer were studied. Incisional biopsy was performed without using electrocautery. Tissue was obtained for histology and estrogen (ER) and progesterone (PR) receptors. Patients received chemotherapy after biopsy. All respond

The toxicity and long-term efficacy of n
The toxicity and long-term efficacy of nedaplatin and paclitaxel treatment as neoadjuvant chemotherapy for locally advanced cervical cancer
✍ Mingzhu Yin; Haiyu Zhang; Huiyan Li; Xia Li; Yunduo Liu; Xiuwei Chen; Ge Lou; Ka πŸ“‚ Article πŸ“… 2011 πŸ› John Wiley and Sons 🌐 English βš– 117 KB

## Abstract ## Background The use of neoadjuvant chemotherapy (NACT) for the treatment of locally advanced cervical cancer (LACC) remains controversial. In current clinical practice, platinum‐based chemotherapy is the major option for patients with LACC. However, serious adverse events have been r

Studies in prognostic factors relating t
Studies in prognostic factors relating to chemotherapy for advanced gastric cancer
✍ Philip T. Lavin; Howard W. Bruckner; Steven C. Plaxe πŸ“‚ Article πŸ“… 1982 πŸ› John Wiley and Sons 🌐 English βš– 689 KB

The prognostic value of pretreatment information relating to prior treatment, demography, physical status, symptoms, disease involvement, pathologic, immunologic, and clinical chemistries were analyzed for a series of 322 patients with advanced gastric cancer. All patients received chemotherapy upon